Global Study Associate Director, Late Development Oncology, Program Management

AstraZeneca

Poland

On-site

PLN 300,000 - 420,000

Full time

7 days ago
Be an early applicant
Application generator

Stand out for this role — generate a tailored resume and cover letter in about a minute.

Get past ATS filters

Job summary

AstraZeneca in Poland is seeking a Global Study Associate Director (GSAD) to drive delivery of complex oncology clinical studies. You will lead cross‑functional study teams, provide strategic direction, and ensure delivery within timelines, budget, and quality standards.

The role acts as the primary AZ liaison from handover to close‑out, coordinating with CPT and external partners. You will oversee documentation, TMF compliance, risk management, and audit readiness while mentoring colleagues and

Responsibilities

  • Lead and coordinate cross-functional study teams to ensure timely milestones
  • Oversee study budget, timelines, and quality against CPT expectations
  • Act as main AZ point of contact for CROs and external partners during outsourced studies
  • Develop essential study documents (CSP through CSR) per AZ SOPs
  • Ensure TMF completion and governance compliance across the study lifecycle
  • Provide regular feedback and mentor team members for professional growth
  • Support process improvements and lead SMO improvement projects

Skills

Cross-functional leadership
Budget management
Stakeholder communication

Job description

The Global Study Associate Director (GSAD) is a business‑critical role within AstraZeneca Late Development Oncology (LDO) whose main accountability is the delivery of clinical studies. The GSAD is responsible for leading a cross‑functional study team (core and extended) and for providing the team with direction and guidance to enable successful study delivery. The GSAD is the main liaison between the study team and the Clinical Program Team (CPT) starting with study handover through to close‑out and archiving. The GSAD is accountable to the CPT for the delivery of a study according to agreed upon timelines, budget and quality standards by ensuring an effective partnership and teamwork within study team and/or external partners.

The GSAD leads the study team and/or study oversight team in accordance with the Study Team Operating Model (STOM), AZ Project Management Framework and/or clinical outsourcing model (SCOUT), current clinical trial regulations (e.g. ICH GCP), AstraZeneca Standard Operating Procedures (AZ SOPs), AZ policies and best practices (e.g. AZ guidelines) and in line with AZ values and behaviours.

Typical Accountabilities:
  • Lead and coordinate a cross‑functional study team of experts in accordance with STOM and its roles, accountabilities and responsibilities framework (RACI) to ensure the clinical study progress as planned driving achievement of milestones according to timelines, budget andquality standards.
  • Lead and facilitate communication across all functions and provide guidance and support to the core and extended study team members as needed and in accordance with study‑specific communication plan.
  • For outsourced studies, be the primary AZ point of contact for the CRO Project Manager to ensure study delivery according to agreed upon timelines, budget and quality standards, while ensuring that the appropriate level of oversight of the CRO is maintained and documented throughout the lifecycle of the study, in accordance with relevant AZ SOPs and guidelines (e.g. description of services and transfer of obligations).
  • Provide input into and hold accountability for the development of essential study level documents (i.e. Clinical Study Protocol (CSP) through to Clinical Study Report (CSR)) in accordance with relevant AZ SOPs.
  • Ensure all external service providers (i.e. central laboratories, IXRS, ePRO, etc.) engaged at the study level are performing to contracted goals and timelines/budget and that adequate oversight is documented.
  • Develop and maintain relevant study plans (e.g. global study management plan and its relevant components such as study project plan SPP) including required input into study level quality and risk management planning (e.g. risk‑based quality management, proactive risk and contingency plans, etc.) ensuring that the risk response strategies and issue escalation pathways are clear to the entire study team.
  • Oversee study level performance against agreed upon plans, milestones and key performance indicators (KPIs, quality and operational) by using company tracking systems and project timelines (e.g. SPP, data flow metrics dashboard, CTMS or eTMF dashboard) and communicate any risks to timelines and/or quality to CPT, along with proposed mitigations.
  • Identify and report quality issues that have occurred within the study in accordance with relevant AZ SOP and collaborate with all functions as necessary to overcome barriers and achieve milestones; proactively communicate findings and corrective action plans (CAPAs) to relevant stakeholders (e.g. CPT, quality assurance staff, functional line management, etc.).
  • Oversee Trial Master File (TMF) completion in accordance with relevant AZ SOPs, including ensuring the TMF plan and Expected Document List (EDL) are in place and that QC activities are performed on an ongoing basis to ensure TMF completeness at all times.
  • Ensure timely compliance with company‑wide governance controls (e.g. Delegation of Authority, SunshineAct, ACCORD attestations, Clinical Trial Transparency).
  • The GSAD is responsible for study budget re‑forecasting following initial budget estimate provided by the CPT and accountable for study budget management through the study lifecycle and for providing budget progress reports to the CPT including any financial risks and mitigation plans (as part of the ongoing study change control process).
  • Ensure studies are inspection‑ready at all times, according to ICH‑GCP and AZ SOP and relevant policies/guidelines; GSAD is the primary Study Management & Operations (SMO) point‑ofcontact in the event of an audit or inspection.
  • Provide regular feedback on individual performance to the study team members and their line managers to support their professional development; may mentor less experienced colleagues.
  • Work on non‑drug project work such as SMO representative in process improvements and/or leading improvement projects as discussed and agreed upon with their manager.

Education, Qu

Get your free, confidential resume review.
or drag and drop your file here.
Similar jobs

Similar jobs worth comparing

Global Study Associate Director, Late Development Oncology, Program Management
Global Study Associate Director, Late Development Oncology, Program Management

AstraZeneca GmbH • Warszawa

On-site
PLN 200,000 - 320,000
Global Study Leader, Late-Development Oncology
Global Study Leader, Late-Development Oncology

AstraZeneca • Poland

On-site
PLN 300,000 - 420,000
Global Study Director, Late-Development Oncology Programs
Global Study Director, Late-Development Oncology Programs

AstraZeneca GmbH • Warszawa

On-site
PLN 200,000 - 320,000
Global Study Associate Director - Single Sponsor dedicated
Global Study Associate Director - Single Sponsor dedicated

IQVIA Argentina • Warszawa

On-site
PLN 226,000 - 419,000
Global Study Associate Director - Single Sponsor dedicated
Global Study Associate Director - Single Sponsor dedicated

IQVIA • Warszawa

On-site
PLN 230,000 - 420,000
Global Study Director – Cross-Functional Lead
Global Study Director – Cross-Functional Lead

IQVIA LLC • Warszawa

Hybrid
PLN 226,000 - 419,000
Manager, Global Clinical Solutions DPS (12-month secondment/FTC)
Manager, Global Clinical Solutions DPS (12-month secondment/FTC)

AstraZeneca • Warszawa

Hybrid
PLN 240,000 - 360,000
Associate Director, Study Data Manager
Associate Director, Study Data Manager

AstraZeneca GmbH • Warszawa

On-site
PLN 350,000 - 520,000
Global Study Associate Director - Single Sponsor dedicated
Global Study Associate Director - Single Sponsor dedicated

IQVIA LLC • Warszawa

Hybrid
PLN 226,000 - 419,000
Senior Study Data Manager & CDM Lead
Senior Study Data Manager & CDM Lead

AstraZeneca • Poland

On-site
PLN 280,000 - 460,000